Cyclerion Therapeutics (KRSA) Stock Price, News & Analysis

Name: Cyclerion Therapeutics Inc (KRSA) Financial Data & Stock Overview
Creator: Stock Titan
License: https://www.stocktitan.net/terms-of-use

KRSA

Published by Stock Titan Data refreshed September 8, 2026

What Changed

Latest news September 8, 2026
Korsana Biosciences Completes Closing of Merger with Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million

Company Description

This page collects what Stock Titan holds for KRSA, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$22.13

Last updated: September 9, 2026 at 12:51

Performance 1 year

Market Cap

Shares outstanding

Latest News

View All

yesterday

—

Korsana Biosciences Completes Closing of Merger with Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million

private placement acquisition

Cyclerion Therapeutics has 1 recent news article, with the latest published yesterday. Key topics include private placement, acquisition. View all KRSA news →

SEC Filings

View All

No SEC filings available for KRSA.

Financial Highlights

—

Revenue (latest FY)

—

Net Income (latest FY)

—

Diluted EPS (latest FY)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months